Puma Biotechnology, Inc.

NASDAQ: PBYI
$8.34
+$0.29 (+3.5%)
Closing price January 28, 2020

Why These Breast Cancer Study Results Look So Promising

Posted: December 12, 2019 at 9:15 am

Puma Biotechnology Inc. (NASDAQ: PBYI) shares made a handy gain early on Thursday after the company presented updated results from its Phase 2 Summit clinical trial of neratinib at the ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Anthem, Ciena, Dollar General, Encana, Lennar, Lululemon, Sage Therapeutics, Target, Tesla, Trade Desk, Yext and More

Posted: December 6, 2019 at 9:00 am

Stocks were indicated to open higher on Friday after a much better than expected payrolls report with a 3.5% unemployment rate. Stocks have been more volatile this week, after hitting ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Apollo, BlackRock, Cloudflare, Green Plains, Microsoft, Oracle, Target, TJX and More

Posted: October 8, 2019 at 8:50 am
Last updated: January 6, 2020 2:12 am

Stocks were indicated to open lower on Tuesday with more concerns over Brexit and concerns that trade talks with China will not yield very much. The bull market is well ...
Read Full Story »

What This Recent FDA Move Could Mean for Breast Cancer Patients With Brain Metastases

Posted: September 4, 2019 at 10:35 am
Last updated: January 6, 2020 2:48 am

Puma Biotechnology Inc. (NASDAQ: PBYI) shares jumped early Wednesday after the announcement that the U.S. Food and Drug Administration (FDA) provided an update on the company’s breast cancer treatment. However, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: American Air, BlackBerry, Mallinkrodt, PG&E, RingCentral, Southwest Airlines, Yeti and More

Posted: November 19, 2018 at 9:00 am
Last updated: January 11, 2020 2:44 pm

  Stocks were indicated to open lower on Monday after weekend news that sounds like a China trade deal is not on the way very soon. Investors have been forced ...
Read Full Story »

Puma Biotech, General Electric Plummet into Friday’s 52-Week Low Club

Posted: November 2, 2018 at 4:04 pm
Last updated: January 11, 2020 3:26 pm

November 2, 2018: Here are four stocks trading with heavy volume among 83 equities making new 52-week lows on Friday. On the NYSE decliners led advancers by about 2.2 to ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Abiomed, Allscripts, Apple, Carbonite, Kraft Heinz, L3, Southern Copper, Starbucks, VeriSign, XPO and More

Posted: November 2, 2018 at 8:55 am
Last updated: January 11, 2020 3:28 pm

  Stocks were indicated to open higher on China trade deal hopes and after a stronger nonfarm payrolls report. While the stock market has bounced handily from the lows at ...
Read Full Story »

Can Puma Biotechnology Break In to Europe?

Posted: June 26, 2018 at 11:35 am
Last updated: January 11, 2020 9:53 pm

Puma Biotechnology Inc. (NASDAQ: PBYI) shares climbed on Tuesday after the company announced that it expects a positive outcome in Europe. Ultimately, the firm believes that neratinib, its treatment of ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AMC, Alkermes, Echostar, Kohls, L Brands, US Bancorp, Sarepta Therapeutics and More

Posted: May 11, 2018 at 9:00 am
Last updated: January 11, 2020 11:46 pm

The futures traded just a touch higher Friday morning as the market continued to digest some big gains from the past two weeks. Stocks took off once again yesterday when ...
Read Full Story »

Breast Cancer Drug Can Bring Exponential Sales Growth for Puma Biotechnology

Posted: April 17, 2018 at 10:00 am
Last updated: January 12, 2020 12:54 am

The world of biotech can be a rags-to-riches story for companies that build up a drug candidate and secure FDA approval for it. And the larger the drug target group ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Albermarle, American Airlines, Ellie Mae, Johnson & Johnson, Mallinckrodt, Mylan, NetApp, Southwest Air and More

Posted: April 12, 2018 at 9:00 am
Last updated: January 12, 2020 1:30 am

Stocks have been swinging up and down for several days now, but the major indices were indicated to open up on Thursday. The bull market may now be over nine ...
Read Full Story »

Why Analysts Are Slashing Their Targets for Puma Biotechnology

Posted: January 24, 2018 at 10:50 am
Last updated: January 12, 2020 4:10 am

Puma Biotechnology Inc. (NASDAQ: PBYI) saw its shares take a dive on Wednesday following regulatory events in Europe. Specifically, the Committee for Medicinal Products for Human Use (CHMP) of the ...
Read Full Story »

50 Mid-Cap and Larger Stocks More Than Doubled in 2017

Posted: December 18, 2017 at 11:50 am
Last updated: January 12, 2020 5:21 am

With 2017 nearing an end, it is important to consider just what has happened. Tax reform looks very likely now, and gross domestic product is higher in the United States ...
Read Full Story »

Puma Biotech Wins Big on FDA Approval of Breast Cancer Treatment

Posted: July 18, 2017 at 11:31 am
Last updated: January 12, 2020 10:02 am

 Shares of Puma Biotechnology, Inc. (NASDAQ: PBYI) touched a multiyear high Tuesday after the company reported a key approval by the U.S. Food and Drug Administration (FDA). Specifically, the agency ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Cameco, Carvana, Chipotle, Magellan Midstream, Netflix, Puma Bio, SeaWorld and More

Posted: July 18, 2017 at 9:25 am
Last updated: January 12, 2020 10:03 am

Stocks were indicated marginally lower on Tuesday, but the major equity indexes remain just under all-time highs. The bull market may now be well over eight years old, but investors ...
Read Full Story »